Dopram (West-ward Pharmaceutical Corp.)


Welcome to the PulseAid listing for the Dopram drug offered from West-ward Pharmaceutical Corp.. This Increased Medullary Respiratory Drive [PE],Respiratory Stimulant [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: West-ward Pharmaceutical Corp.
NON-PROPRIETARY NAME: Doxapram hydrochloride
SUBSTANCE NAME: DOXAPRAM HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Increased Medullary Respiratory Drive [PE],Respiratory Stimulant [EPC]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1965-06-23
END MARKETING DATE: 0000-00-00


Dopram HUMAN PRESCRIPTION DRUG Details:

Item DescriptionDopram from West-ward Pharmaceutical Corp.
LABELER NAME: West-ward Pharmaceutical Corp.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/mL)
START MARKETING DATE: 1965-06-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0641-6018_7c74602f-5167-4f3d-8912-f6016b2eb99e
PRODUCT NDC: 0641-6018
APPLICATION NUMBER: NDA014879

Other DOXAPRAM HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
West-ward Pharmaceutical Corp.Dopram